Spine & Neurosurgery Group

Spine & Neurosurgery Group

  • Home
  • Research
    • Our Research
    • Non-Traumatic Spinal Cord Injury
    • Traumatic Spinal Cord Injury
    • Artificial Intelligence
    • Others
  • Team
    • Our Team
    • Gallery
  • Opportunities
  • News & Highlights
    • News & Highlights
    • Events
    • Publications
    • Awards
  • Contact

Traumatic Spinal Cord Injury Studies

The Rick Hansen Spinal Cord Injury Registry (RHSCIR)

Dr. Henry Ahn leads this long-term nationwide registry study monitoring outcomes for individuals with spinal cord injury across all care stages, from pre-hospitalization to community reintegration. The study aims to build a comprehensive national database to support clinical care, quality improvement, research, and collaboration.    

(Praxis Spinal Cord Institute)

Traumatic Incomplete Tetraplegia Without Instability: A Prospective Multicenter Feasibility Study of Outcomes and Prognosis (IN-TWIN)

Dr. Jefferson Wilson leads this prospective international observational study of patients with ASIA D cervical spinal cord injury. The study aims to establish outcome measures—including patient questionnaires and clinical assessments—that effectively capture changes in milder cervical SCI cases, while evaluating the feasibility of these measures to guide optimal management and treatment.

(AO Foundation)

The Canadian-American Spinal Cord Perfusion Pressure and Biomarker Study (CASPER)

Dr. Jefferson Wilson leads this prospective, multicenter study, which includes cervical and thoracic acute traumatic spinal cord injury (SCI) patients graded ASIA A, B, or C. Within 48 hours of injury, participants receive a lumbar intrathecal catheter for cerebrospinal fluid (CSF) collection and intrathecal pressure (ITP) monitoring. The study aims to:

1. Assess whether maintaining spinal cord perfusion pressure (SCPP) ≥ 65 mmHg improves neurological recovery, measured by ASIA grade conversion and motor score improvement.

2. Collect and store CSF and blood samples to analyze neurochemical biomarkers for future biomarker research.

The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation Study (I-SCRIBBLE)

Dr. Jefferson Wilson leads this longitudinal study that aims to evaluate the accuracy of blood-based biomarkers—neurofilament light chain (NF-L) and glial fibrillary acidic protein (GFAP)—in predicting the severity and long-term outcomes of neurologic impairment following traumatic spinal cord injury (SCI). Adults with acute blunt SCI (AIS grade A–D) will have blood samples collected at multiple time points up to 12 months postinjury. A control group of patients with spinal trauma but without neurologic injury will also be included. Biomarker levels will be correlated with standardized neurological and functional assessments to assess their predictive value.

Return to RESEARCH

Spine & Neurosurgery Group

Contact

30 Bond St
Toronto, ON, M5B 1W8, Canada
(416)-360-4000

Follow Us

  • X

Copyright © 2025 SMHNSSLAB Site. All rights reserved. Created by Rinko Lau. Powered by WordPress. Trauma and Neurosurgery Group.